Loading...
Grown Rogue International Inc.
GRUSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.40
$0.00(0.00%)
Grown Rogue International Inc. (GRUSF) Financial Performance & Income Statement Overview
Review Grown Rogue International Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
23.77%
↑ 23.77%
Operating Income Growth
-56.20%
↓ 56.20%
Net Income Growth
-2020.60%
↓ 2020.60%
Operating Cash Flow Growth
24.35%
↑ 24.35%
Operating Margin
2.73%
↑ 2.73%
Gross Margin
49.75%
↑ 49.75%
Net Profit Margin
-41.84%
↓ 41.84%
ROE
-89.48%
↓ 89.48%
ROIC
3.16%
↑ 3.16%
Grown Rogue International Inc. (GRUSF) Income Statement & Financial Overview
Review Grown Rogue International Inc.'s (GRUSF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.65M | $6.99M | $7.72M | $6.65M |
| Cost of Revenue | $2.77M | $3.07M | $4.34M | $3.40M |
| Gross Profit | $2.88M | $3.92M | $3.38M | $3.26M |
| Gross Profit Ratio | $0.51 | $0.56 | $0.44 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.52M | $1.90M | $2.53M | $1.65M |
| Operating Expenses | $3.80M | $2.95M | $2.74M | $1.90M |
| Total Costs & Expenses | $6.56M | $6.02M | $7.09M | $5.30M |
| Interest Income | -$442807.00 | -$486057.00 | -$505192.00 | -$425648.00 |
| Interest Expense | $619101.00 | $873226.00 | $458040.00 | $471350.00 |
| Depreciation & Amortization | $637482.00 | $811738.00 | $776420.00 | $694684.00 |
| EBITDA | $3.48M | $1.28M | $1.10M | $1.74M |
| EBITDA Ratio | $0.62 | $0.18 | $0.14 | $0.26 |
| Operating Income | -$911430.00 | $976708.00 | $127570.00 | $545431.00 |
| Operating Income Ratio | -$0.16 | $0.14 | $0.02 | $0.08 |
| Other Income/Expenses (Net) | $3.14M | -$1.39M | -$7.15M | -$4.34M |
| Income Before Tax | $2.22M | -$408358.00 | -$7.02M | -$3.80M |
| Income Before Tax Ratio | $0.39 | -$0.06 | -$0.91 | -$0.57 |
| Income Tax Expense | $513937.00 | $258882.00 | $552481.00 | $370525.00 |
| Net Income | $1.37M | -$798017.00 | -$7.68M | -$4.20M |
| Net Income Ratio | $0.24 | -$0.11 | -$1.00 | -$0.63 |
| EPS | $0.007 | -$0.004 | -$0.04 | -$0.02 |
| Diluted EPS | $0.007 | -$0.003 | -$0.04 | -$0.02 |
| Weighted Avg Shares Outstanding | $209.44M | $221.21M | $210.44M | $183.18M |
| Weighted Avg Shares Outstanding (Diluted) | $209.44M | $249.84M | $210.44M | $214.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan